Efficacy and Safety According to the Dose of Valganciclovir for Cytomegalovirus Prophylaxis in Transplantation: Network Meta-analysis Using Recent Data-Reference-Cited by-同舟云学术

Efficacy and Safety According to the Dose of Valganciclovir for Cytomegalovirus Prophylaxis in Transplantation: Network Meta-analysis Using Recent Data

Published:2021-07 Issue:6 Volume:53 Page:1945-1950
ISSN:0041-1345
Container-title:Transplantation Proceedings
language:en
Short-container-title:Transplantation Proceedings

Author:

Lee Jin Ho,Lee Heeryong,Lee Seoung Woo,Hwang Seun Deuk,Song Joon Ho

Funder

National Research Foundation of Korea

Ministry of Science and ICT, South Korea

Publisher

Elsevier BV

Subject

Transplantation,Surgery

Reference31 articles.

1. Effects of the intensity of immunosuppressive therapy on outcome of treatment for CMV disease in organ transplant recipients;Asberg;Am J Transplant,2010

2. Prediction of recurrent cytomegalovirus disease after treatment with ganciclovir in solid-organ transplant recipients;van den Berg;Transplantation,1993

3. Clinical and epidemiological predictors of recurrent cytomegalovirus disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG Study Group;Falagas;Clin Infect Dis,1997

4. Influence of cytomegalovirus disease in outcome of solid organ transplant patients;Linares;Transplant Proc,2011

5. Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival;Sagedal;Kidney Int,2004

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update;Transplantation Reviews;2024-12

2. Challenges for the improvement of valganciclovir prophylaxis in solid organ transplantation and the possible role of therapeutic drug monitoring in adults;British Journal of Clinical Pharmacology;2024-06-18

3. Low-Dose Valganciclovir Prophylaxis Against Cytomegalovirus in Intermediate-Risk Liver and Dual-Abdominal Transplant Recipients;Annals of Pharmacotherapy;2024-05-27

4. Pitfalls in Valganciclovir Prophylaxis Dose Adjustment Based on Renal Function in Kidney Transplant Recipients;Transplant International;2024-05-09

5. ОНОВЛЕНІ УЗАГАЛЬНЕНІ РЕКОМЕНДАЦІЇ З ЛІКУВАННЯ ГЕРПЕСВІРУСНИХ ІНФЕКЦІЙ ЛЮДИНИ;Journal of Dermatovenereology and Cosmetology named after N.A.Torsuiev;2024-02-08